Search all trials

Find therapies in clinical trials near you – page 17

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Colorectal cancer+3

Recruiting

Registered drug

Study on Tislelizumab for Cancer Patients with Molecular Residual Disease After Standard Treatment

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Sodium Chloride

Contact Research Centre

Hormone-dependent prostate cancer

Recruiting

Registered drugNo placebo

Study on the Effectiveness of Lutetium (177Lu) Vipivotide Tetraxetan with Standard Treatment for Men with Metastatic Hormone-Sensitive Prostate Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Abiraterone Acetate

Contact Research Centre

Renal cell carcinoma

Recruiting

Registered drugNo placebo

Study on Cabozantinib and Drug Combination for Untreated Metastatic Renal Cell Carcinoma in Intermediate and Poor Risk Patients

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Axitinib

Contact Research Centre

Diffuse large B-cell lymphoma

Recruiting

Registered drugNo placebo

Study on Golcadomide for Patients with Relapsed or Refractory Aggressive Large B-Cell Lymphoma at High Risk of Relapse After CAR T-Cell Therapy

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Golcadomide

Contact Research Centre

Neuroendocrine tumour

Recruiting

Registered drugNo placebo

Study on Retreatment with Lutetium (177Lu) Oxodotreotide for Patients with Intestinal Neuroendocrine Tumors

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:L-Arginine Hydrochloride

Contact Research Centre

Rectal cancer

Recruiting

Registered drugNo placebo

Study on Managing Locally-Advanced Rectal Cancer with Oxaliplatin, Fluorouracil, and Irinotecan Hydrochloride for Patients Responding Well to Initial Chemotherapy

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Calcium Folinate

Contact Research Centre

Cardiogenic shock

Recruiting

Registered drugNo placebo

Study on the Effects of Empagliflozin for Patients with Cardiogenic Shock

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Empagliflozin

Contact Research Centre

Study on Everolimus and Lutetium (177Lu) Oxodotreotide for Treating Grades 2 and 3 Refractory Meningioma in Patients

Recruiting

Registered drugNo placebo

Study on Everolimus and Lutetium (177Lu) Oxodotreotide for Treating Grades 2 and 3 Refractory Meningioma in Patients

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Everolimus

Contact Research Centre

Endometrial cancer+4

Recruiting

InvestigationalNo placebo

Study of PC14586 for Patients with Advanced Solid Tumors with a Specific TP53 Mutation

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Pc14586

Contact Research Centre

Soft tissue sarcoma

Recruiting

Registered drugNo placebo

Comparison of Cyclophosphamide and Doxorubicin for Treatment of Advanced or Metastatic Soft Tissue Sarcoma in Patients Age 65 and Older

Registered drugNo placebo

France

Participants:65+ years
Substances:Cyclophosphamide

Contact Research Centre

Rheumatoid arthritis

Recruiting

Registered drug

Study on Baricitinib and Anti-TNF Drug Combination for Patients with Rheumatoid Arthritis

Registered drug

France

Participants:18–64 years
Substances:Adalimumab

Contact Research Centre

Neoplasm

Recruiting

InvestigationalNo placebo

Study of Patritumab Deruxtecan for Patients with Advanced or Metastatic Solid Tumors

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Patritumab Deruxtecan

Contact Research Centre

Find therapies in clinical trials near you – page 17

583 trials match your criteria

Colorectal cancer+3

Study on Tislelizumab for Cancer Patients with Molecular Residual Disease After Standard Treatment

Hormone-dependent prostate cancer

Study on the Effectiveness of Lutetium (177Lu) Vipivotide Tetraxetan with Standard Treatment for Men with Metastatic Hormone-Sensitive Prostate Cancer

Renal cell carcinoma

Study on Cabozantinib and Drug Combination for Untreated Metastatic Renal Cell Carcinoma in Intermediate and Poor Risk Patients

Diffuse large B-cell lymphoma

Study on Golcadomide for Patients with Relapsed or Refractory Aggressive Large B-Cell Lymphoma at High Risk of Relapse After CAR T-Cell Therapy

Neuroendocrine tumour

Study on Retreatment with Lutetium (177Lu) Oxodotreotide for Patients with Intestinal Neuroendocrine Tumors

Rectal cancer

Study on Managing Locally-Advanced Rectal Cancer with Oxaliplatin, Fluorouracil, and Irinotecan Hydrochloride for Patients Responding Well to Initial Chemotherapy

Cardiogenic shock

Study on the Effects of Empagliflozin for Patients with Cardiogenic Shock

Study on Everolimus and Lutetium (177Lu) Oxodotreotide for Treating Grades 2 and 3 Refractory Meningioma in Patients

Study on Everolimus and Lutetium (177Lu) Oxodotreotide for Treating Grades 2 and 3 Refractory Meningioma in Patients

Endometrial cancer+4

Study of PC14586 for Patients with Advanced Solid Tumors with a Specific TP53 Mutation

Soft tissue sarcoma

Comparison of Cyclophosphamide and Doxorubicin for Treatment of Advanced or Metastatic Soft Tissue Sarcoma in Patients Age 65 and Older

Rheumatoid arthritis

Study on Baricitinib and Anti-TNF Drug Combination for Patients with Rheumatoid Arthritis

Neoplasm

Study of Patritumab Deruxtecan for Patients with Advanced or Metastatic Solid Tumors

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.